Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Ovarian Neoplasms 1Kidney Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Early Intervention, Educational 5Radiotherapy 4Psychiatric Rehabilitation 4sargramostim 3pembrolizumab 3Trastuzumab 3Methods 3palbociclib 2cediranib 2Standard of Care 2Specimen Handling 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Irinotecan 2Interleukin-12 Subunit p35 2Interferon-alpha 2Fluorouracil 2Fluorodeoxyglucose F18 2Erlotinib Hydrochloride 2Docetaxel 2Counseling 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sapanisertib 1relatlimab 1pertuzumab 1osimertinib 1orantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Health Promotion × Genitourinary × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡